Regulatory Pathway Distinctions:
510(k) Clearance: Establishes substantial equivalence to a legally marketed predicate device (21 CFR 807).
PMA Approval: Rigorous evaluation establishing reasonable assurance of safety and effectiveness for high-risk Class III devices.
Adverse Event Disclaimers: Reports from FDA MAUDE represent voluntary notifications and do not verify proven clinical causation.